Healthcare M&A niche Boutique investment bank specialized in healthcare sectors with deal experience across biotech, diagnostics, HCIT, devices, services, and pharmaceuticals, indicating strong potential for cross-market M&A advisory and cap markets introductions.

Mid-market focus Typically handles enterprise values from five to five hundred million dollars and capital raises from five to two hundred million dollars, suggesting sales opportunities with mid-market healthcare companies seeking strategic transactions and capital partner introductions.

Global reach Active relationships with national and international clients including European, Indian, Asian and emerging markets, presenting opportunities to source cross-border deals and advisory mandates for multinational healthcare firms.

Full-service capabilities Offers M&A advisory, capital markets access (public/private equity, subordinated and senior debt), and business development partnerships (in-licensing/out-licensing, channel partnerships), enabling upsell to holistic corporate finance and strategic alliance engagements.

Regulatory credibility Registered broker/dealer and FINRA member with SIPC protection, which can streamline due diligence, increase client trust, and shorten sales cycles for prospective clients seeking compliant advisory and capital-raising services.